Results 31 to 40 of about 6,409,949 (276)

Physiotherapy management of functional movement disorders: the patient perspective

open access: yesDisability and Rehabilitation, 2023
Purpose People with functional movement disorders (FMD) are commonly seen in neurology clinics. Despite a recent increase in research, no standardised treatment pathway across the UK exists. Currently only a few qualitative studies in FMD with a focus on
Debbie Zeun, Heather Hunter
semanticscholar   +1 more source

Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Mutations in the NMDA receptor are known to disrupt glutamatergic signaling crucial for early neurodevelopment, often leading to severe global developmental delay/intellectual disability, epileptic encephalopathy, and cerebral palsy phenotypes.
Sara A. Lewis   +15 more
doaj   +1 more source

Living with functional movement disorders: a tale of three battles. An interpretative phenomenological analysis

open access: yesPsychology and Health, 2022
Objectives Functional movement disorders (FMD) have poor prognosis and high physical and psychological co-morbidity. Their pathogenesis remains unclear, clinicians often find them difficult to treat, and lack of agreement between healthcare providers and
Sylwia Bazydlo, Fiona J. R. Eccles
semanticscholar   +1 more source

Pre-dopa Deep Brain Stimulation: Is Early Deep Brain Stimulation Able to Modify the Natural Course of Parkinson’s Disease?

open access: yesFrontiers in Neuroscience, 2020
Deep brain stimulation (DBS) is an established therapy for the management of Parkinson’s disease (PD). However, DBS is indicated as the disease progresses and motor complications derived from pharmacological therapy arise. Here, we evaluate the potential
Mauro Porta   +4 more
doaj   +1 more source

Functional movement disorders. [PDF]

open access: yes, 2020
Functional movement disorders (FMD) represent a complex and disabling entity characterized by a broad range of clinical symptoms not explained by a classical neurological disease. In 2013, the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
Moulin, T.   +10 more
core   +1 more source

Diagnosis and Initial Treatment of Functional Movement Disorders in Children.

open access: yesSeminars in Pediatric Neurology, 2022
Functional movement disorders (FMD) are complex neurobehavioral disorders that can be a significant source of disability for both children and their caregivers. While FMD in the adult population is better characterized, the aim of this paper is to review
Travis R. Larsh   +3 more
semanticscholar   +1 more source

Wearable systems in movement disorders

open access: yes, 2023
Wearable systems are research-grade or commercial electronic instruments designed to be worn by the user and to serve a variety of purposes. These devices can detect and collect various health-related parameters, such as movement, heart rate, temperature,
Maetzler, Walter, Bianchini, Edoardo
core   +1 more source

Functional Inhibitory Control Dynamics in Impulse Control Disorders in Parkinson’s Disease [PDF]

open access: yes, 2020
Published online 11 November 2019ABSTRACT: Background: Impulse control disorders related to alterations in the mesocorticolimbic dopamine network occur in Parkinson’s disease (PD).
Quiroga-Varela, A.   +26 more
core   +1 more source

Transitional Care for Young People with Movement Disorders: Consensus-Based Recommendations from the MDS Task Force on Pediatrics [PDF]

open access: yes, 2023
Movement disorders: PediatricsTrastornos del movimiento; PediatríaTrastorns del moviment; PediatriaBackground The International Parkinson and Movement Disorders Society (MDS) set up a working group on pediatric movement disorders (MDS Task Force on ...
Shalash, Ali   +6 more
core   +1 more source

Subjective Cognitive Complaints in Cognitively Normal Patients With Parkinson's Disease: A Systematic Review [PDF]

open access: yes, 2023
Subjective cognitive complaints (SCCs) refer to self-perceived cognitive decline and are related to objective cognitive decline. SCCs in cognitively normal individuals are considered a preclinical sign of subsequent cognitive impairment due to Alzheimer ...
이필휴
core   +1 more source

Home - About - Disclaimer - Privacy